AVBP
ArriVent BioPharma, Inc.
30.10$
-0.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| -9.86 | -1.30 | -1.75 | -2.23 | -4.18 | |
| – | – | – | – | -0.08 | |
| 0.05 | 0.01 | 0.03 | 0.10 | 0.33 | |
| -3.09 | -0.21 | 0.39 | 0.22 | -0.10 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -31.34 | – | – | -6.12 | -1.85 | |
| – | 0.00 | – | – | – | |
| 70.41 | 5.07 | 1.34 | 5.93 | 5.28 | |
| 29.21 | 3.76 | -0.41 | -2.42 | -0.75 | |
| -9.86 | -1.30 | -1.75 | -2.23 | -4.18 |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.